Wedelolactone attenuates cerebral ischemia-reperfusion injury by blocking GPX4-mediated ferroptosis

Cerebral ischemia is currently the third leading cause of death worldwide. Among its complications, cerebral ischemia-reperfusion (I/R) is considered the most inevitable problem. To address this condition, there is a need for the development of more drugs. Wedelolactone, the main active chemical component extracted from dried lotus leaves, exhibits a wide range of pharmacological effects. Here we constructed an oxygen-glucose deprivation/reperfusion (OGD/R) model. Cell counting kit-8 (CCK-8) assays evaluated the impact of Wedelolactone on cell growth. Real-time quantitative polymerase chain reaction (RT-qPCR) assessed its effects on inflammation. We employed 2′,7′-Dichlorofluorescein (DCF) staining and an iron detection kit to measure ferroptosis. Flow cytometry (FCM) and immunoblot assays were utilized to investigate cell apoptosis. The results showed that Wedelactone promoted OGD-induced HT-22 cell viability and alleviated OGD/R-induced cellular inflammation, OGD/R-stimulated ferroptosis and OGD/R-induced apoptosis. Mechanically, Wedelactone inhibited OGD/R-stimulated ferroptosis via mediating glutathione peroxidase 4 (GPX4) expression. In conclusion, Wedelolactone may attenuate cerebral ischemia-reperfusion (CIR)/I by blocking GPX4-mediated ferroptosis.

Cerebral ischemia-reperfusion (I/R); Wedelolactone; Apoptosis; Ferroptosis; GPX4

[1] Xu X, Chua CC, Gao J, Chua K, Wang H, Hamdy RC, et al. Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway. Brain Research. 2008; 1227: 12–18.

[2] Zhou J, Zhou S. Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity. Journal of Ethnopharmacology. 2010; 132: 15–27.

[3] Yang MH, Baek SH, Hwang ST, Um JY, Ahn KS. Corilagin exhibits differential anticancer effects through the modulation of STAT3/5 and MAPKs in human gastric cancer cells. Phytotherapy Research. 2022; 36: 2449–2462.

[4] Huang H, Zhong R, Xia Z, Song J, Feng L. Neuroprotective effects of rhynchophylline against ischemic brain injury via regulation of the Akt/mTOR and TLRs signaling pathways. Molecules. 2014; 19: 11196–11210.

[5] Zhang H, Liu M, Ji X, Jiang C, Li Z, OuYang B. Gastrodin combined with rhynchophylline inhibits cerebral ischaemia-induced inflammasome activation via upregulating miR-21-5p and miR-331-5p. Life Sciences. 2019; 239: 116935.

[6] Zhu MM, Wang L, Yang D, Li C, Pang ST, Li XH, et al. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IkK/IkB/NF-kB pathway. Biomed Pharmacother. 2019; 117: 109088.

[7] Fan R, Sui J, Dong X, Jing B, Gao Z. Wedelolactone alleviates acute pancreatitis and associated lung injury via GPX4 mediated suppression of pyroptosis and ferroptosis. Free Radical Biology and Medicine. 2021; 173: 29–40.

[8] Wang G, Bi Y, Xiong H, Bo T, Han L, Zhou L, et al. Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2. Human & Experimental Toxicology. 2021; 40: S447–S459.

[9] Sun L, Sun W, Liu M, Li N, Liu Y, Cao X, et al. Wedelolactone induces natural killer cell activity and the improvement to bioavailability using polysaccharides from Ligustri Lucidi Fructus. International Journal of Biological Macromolecules. 2023; 244: 125208.

[10] Wei L, Chen Y, Yu Q, Wang Y, Liu G. Patchouli alcohol protects against ischemia/reperfusion-induced brain injury via inhibiting neuroinflammation in normal and obese mice. Brain Research. 2018; 1682: 61–70.

[11] Li C, Sun G, Chen B, Xu L, Ye Y, He J, et al. Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke. Pharmacological Research. 2021; 174: 105933.

[12] Wang Z, Li Y, Ye Y, Zhu H, Zhang J, Wang H, et al. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis. Brain Research Bulletin. 2023; 193: 37–46.

[13] Suzuki S, Ota Y, Sano R, Morimoto Y, Moriya T, Shiota M. Growing teratoma syndrome after surgery for ovarian immature teratoma. European Journal of Gynaecological Oncology. 2022; 43: 115–122.

[14] Li L, Shen Z, Yang W, Wu W, Liu W, Chen Z. Cerebroprotective effects of dimeric copper(II) Bis(o-acetoxybenzoate) on ischemia-reperfusion injury in Gerbils. Metal-Based Drugs. 2002; 8: 253–256.

[15] Qin W, Yang L, Chen X, Ye S, Liu A, Chen D, et al. Wedelolactone promotes the chondrogenic differentiation of mesenchymal stem cells by suppressing EZH2. International Journal of Stem Cells. 2023; 16: 326–341.

[16] Ha NM, Hop NQ, Son NT. Wedelolactone: a molecule of interests. Fitoterapia. 2023; 164: 105355.

[17] Bhattacharyya S, Law S. Environmental pollutant N-N’ethylnitrosourea-induced leukemic NLRP3 inflammasome activation and its amelioration by Eclipta prostrata and its active compound wedelolactone. Environmental Toxicology. 2022; 37: 322–334.

[18] Luan Y, Luan Y, He H, Jue B, Yang Y, Qin B, et al. Glucose metabolism disorder: a potential accomplice of SARS-CoV-2. International Journal of Obesity. 2023; 47: 893–902.

[19] Zhang J, Zhang M, Huo X, Ning J, Yu Z, Morisseau C, et al. Macrophage inactivation by small molecule wedelolactone via targeting sEH for the treatment of LPS-induced acute lung injury. ACS Central Science. 2023; 9: 440–456.

[20] Feng L, Li ZY, Wang L, Li XH, Chen YP, Yang B, et al. Wedelolactone-loaded micelles ameliorate doxorubicin-induced oxidative injury in podocytes by improving permeability and bioavailability. Frontiers in Bioengineering and Biotechnology. 2019; 7: 333.